Belgian experience with triple therapy with boceprevir and telaprevir in genotype 1 infected patients who inject drugs

A. Arain, S. Bourgeois, C. de Galocsy, J. Henrion, P. Deltenre, F. d'Heygere, C. George, B. Bastens, L. Van Overbeke, R. Verrando, L. Bruckers, C. Mathei, F. Buntinx, H. Van Vlierberghe, S. Francque, W. Laleman, C. Moreno, F. Janssens, F. Nevens, G. Robaeys

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)94-99
Number of pages6
JournalJournal of Medical Virology
Issue number1
Publication statusPublished - Jan 2016


  • hepatitis C
  • direct acting antivirals
  • telaprevir
  • boceprevir
  • persons who inject drugs

Cite this